Ligand Pharmaceuticals Is A Low-Risk Way To Bet On Biopharma Growth: Analyst
Bank of America (BofA) Securities on Wednesday initiated coverage on Ligand Pharmaceuticals Inc (NASDAQ:LGND), citing the distinctive royalty firm offers compelling upside. Ligand's Differentiated Model Ligand is a biopharmaceutical royalty aggregator …